Macrocyclic compound and uses thereof
US10954249B2 · kind B2 · utility
6Cited by
30References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 3, 2018 |
| Grant date | Mar 23, 2021 |
| Priority date | — |
| Expiry date | Apr 3, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel Compound (1) having tumor vascular remodeling effect and/or anti-CAF (Cancer Associated Fibroblasts) activity, or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable and medical uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.